These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 136059)

  • 1. Studies on the degradation of fibrinogen Giessen I.
    Bleyl H; Krause WH
    Thromb Res; 1976 Oct; 9(4):329-34. PubMed ID: 136059
    [No Abstract]   [Full Text] [Related]  

  • 2. Degradation of human fibrinogen by plasmin: a kinetic study.
    Regañon E; Aznar J; Vila V
    Thromb Res; 1977 Mar; 10(3):411-9. PubMed ID: 140473
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin(-ogen) interactions with plasmin.
    Gaffney PJ
    Haemostasis; 1977; 6(1):2-25. PubMed ID: 140113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex-formation between the fibrin-derived plasmic fragments DD and E demonstrated by crossed immunoelectrophoresis.
    Gogstad GO; Brosstad F
    Thromb Res; 1983 Jun; 30(5):441-8. PubMed ID: 6225217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of inhibition of fibrinolysis and fibrinogenolysis by the end fibrinogen degradation products.
    Khavkina LS; Rozenfeld MA; Leonova VB
    Thromb Res; 1995 Apr; 78(2):173-87. PubMed ID: 7482434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antiplasmin activity of the E fragments of fibrin and fibrinogen].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1990; (4):511-8. PubMed ID: 2148755
    [No Abstract]   [Full Text] [Related]  

  • 9. The fibrinolytic system and haemostasis.
    Chesterman CN
    Thromb Diath Haemorrh; 1975 Nov; 34(2):368-77. PubMed ID: 53891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 2-plasmin inhibitor deficiency.
    Lipinski B; Gurewich V
    Lancet; 1979 Feb; 1(8111):329. PubMed ID: 84984
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinogen and fibrin split products and their biological importance].
    Krantz S; Fiedler H; Lober M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(1):1-13. PubMed ID: 4110779
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological behavior of higher molecular weight products of fibrinolysis.
    Chang ML; Bang NU
    J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB; Bradford TR; Littman BH; Wintroub BU
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nature and biological activities of degradation products of fibrinogen and fibrin.
    Kwaan HC; Barlow GH
    Annu Rev Med; 1973; 24():335-44. PubMed ID: 4575863
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinogen Haifa: fibrinogen variant with absence of protective effect of calcium on plasmin degradation of gamma chains.
    Soria J; Soria C; Samama M; Tabori S; Kehl M; Henschen A; Nieuwenhuizen W; Rimon A; Tatarski I
    Thromb Haemost; 1987 Jun; 57(3):310-3. PubMed ID: 2958955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen and its derivatives, hereditary and acquired abnormalities.
    Marder VJ; Buszynski AZ
    Schweiz Med Wochenschr; 1974 Sep; 104(39):1338-42. PubMed ID: 4421373
    [No Abstract]   [Full Text] [Related]  

  • 17. Human fibrinogen heterogeneity. A study of limited fibrinogen degradation.
    Regañón E; Vila V; Aznar J; Laiz B
    Clin Chim Acta; 1989 Sep; 184(1):7-17. PubMed ID: 2532081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen Bondy: a new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules.
    Jandrot-Perrus M; Aurousseau MH; Rabiet MJ; Josso F
    Thromb Res; 1982 Sep; 27(6):659-70. PubMed ID: 6217586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinopeptide release from fibrinogen Paris I.
    Finlayson JS; Reamer LA; Mosesson MW; Menache D
    Thromb Res; 1980 Feb 1-15; 17(3-4):577-9. PubMed ID: 7368177
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
    Arnesen H
    J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.